Medscape Education is honored to be a Friend of COA sponsor at the Community Oncology Conference, taking place from April 28-30th in Orlando, FL. This ...

Johnson & Johnson (J&J) has announced that its dual-acting IL-23 inhibitor Tremfya (guselkumab) has been approved by the ...

Boehringer Ingelheim and Tessellate Bio have entered into a partnership worth over €500m to develop oral precision medicines ...

Ipsen’s elafibranor has shown promise as a treatment for primary sclerosing cholangitis (PSC), a rare liver disease that ...

But the legal and regulatory framework is evolving to keep pace. The EU AI Act, GDPR and medical device regulations are ...